Pradaxa.ie

For Republic of Ireland healthcare
professionals only

For treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE),
and prevention of recurrent DVT and PE in adults^1,2

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults^1,2

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.

Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 1850 946100.

SPCs

References:

Boehringer Ingelheim. Pradaxa^® 150mg hard capsules Summary of Product Characteristics.
Boehringer Ingelheim. Pradaxa^® 110mg hard capsules Summary of Product Characteristics.